Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease

Current Opinion in Pediatrics

Volumn 25, Issue 2, 2013, Pages 193-200

  Cowan, Eileen ^a   Nandivada, Prathima ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Fat emulsion; Fish oil; Parenteral; Parenteral nutrition associated liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; CLINOLEIC; FISH OIL; FISH OIL BASED LIPID EMULSION; GAMMA GLUTAMYLTRANSFERASE; INTRALIPID; LEUKOTRIENE; LIPID EMULSION; LIPOFUNDIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGAVEN; PHYTOSTEROL; PROSTAGLANDIN; SAFFLOWER OIL PLUS SOYBEAN OIL; SOYBEAN OIL; THROMBOXANE; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOODSTREAM INFECTION; BRAIN HEMORRHAGE; CHOLESTASIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ESSENTIAL FATTY ACID DEFICIENCY; FATTY LIVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INTESTINAL FAILURE; LENGTH OF STAY; LIVER DISEASE; LOW BIRTH WEIGHT; LOW FAT DIET; LUNG DYSPLASIA; NONHUMAN; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; REVIEW; SHORT BOWEL SYNDROME; TOTAL PARENTERAL NUTRITION;

CHILD; CHILD, PRESCHOOL; DRUG-INDUCED LIVER INJURY; FAT EMULSIONS, INTRAVENOUS; FISH OILS; HUMANS; INFANT; PARENTERAL NUTRITION; PLANT OILS;

EID: 84875382635     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32835e02ac     Document Type: Review

References (58)

1. Dudrick SJ, Wilmore DW, Vars HM, Rhoads J. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968; 64:134-142.
2. Carter BA, Karpen SJ. Intestinal-failure-associated liver disease: Management and treatment strategies past, present, and future. Semin Liver Dis 2007; 27:251-258.
3. Le HD, de Meijer VE, Robinson EM, et al. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr 2011; 94:749-758.
4. Jeejeebhoy KN. Parenteral nutrition in the intensive care unit. Nutr Rev 2012; 70:623-630.
5. Tillman EM. Review and clinical update on parenteral nutrition-associated liver disease. Nutr Clin Pract 2013; 28:30-39.
6. Kelly DA. Preventing parenteral nutrition liver disease. Early Hum Dev 2010; 86:683-687.
7. Rangel SJ, Calkins CM, Cowles RA, et al. American Pediatric Surgical Association Outcomes and Clinical Trials Committee. Parenteral nutritionassociated cholestasis: An American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg 2012; 47:225-240.
8. Kelly DA. Intestinal failure-associated liver disease: what do we know today? Gastroenterology 2006; 130 (2 Suppl 1):S70-S77.
9. Colomb V, Jobert-Giraud A, Lacaille F, et al. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. J Parenter Enteral Nutr 2000; 24:345-350.
10. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000; 132:525-532.
11. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998; 14:158-164.
12. Clayton PT, Bowron A, Mills KA, et al. Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 1993; 105:1806-1813.
13. Llop JM, Virgili N, Moreno-Villares JM, et al. Phytosterolemia in parenteral nutrition patients: Implications for liver disease development. Nutrition 2008; 24:1145-1152.
14. Ellega° rd L, Sunesson A, Bosaeus I. High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clin Nutr 2005; 24:415-420.
15. Kurvinen A, Nissinen MJ, Gylling H, et al. Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure. J Pediatr Gastroenterol Nutr 2011; 53:440-446.
16. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract 2006; 21:279-290.
17. Squires RH, Duggan C, Teitelbaum DH, et al. Pediatric Intestinal Failure Consortium. Natural history of pediatric intestinal failure: Initial report from the Pediatric Intestinal Failure Consortium. J Pediatr 2012; 161:723-728.
18. Bishay M, Pichler J, Horn V, et al. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition. J Pediatr Surg 2012; 47:359-362.
19. Meisel JA, Le HD, de Meijer VE, et al. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg 2011; 46:666-673.
20. Kurvinen A, Nissinen MJ, Andersson S, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012; 54:803-811.
21. Iyer KR, Spitz L, Clayton P. BAPS prize lecture: New insight into mechanisms of parenteral nutrition-associated cholestasis: Role of plant sterols. British Association of Paediatric Surgeons. J Pediatr Surg 1998; 33:1-6.
22. Carter BA, Taylor OA, Prendergast DR, et al. Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR. Pediatr Res 2007; 62:301-306.
23. Sinal CJ, Tohkin M, Miyata M, et al. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000; 102:731-744.
24. Wang H, Chen J, Hollister K, et al. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3:543-553.
25. Boberg KM, Akerlund JE, Bjo? rkhem I. Effect of sitosterol on the ratelimiting enzymes in cholesterol synthesis and degradation. Lipids 1989; 24:9-12.
26. Shefer S, Salen G, Nguyen L, et al. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis: Effect on cholesterol 7 alpha-hydroxylase. J Clin Invest 1988; 82:1833-1839.
27. Calder P. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007; 77:327-335.
28. Carlson SJ, Fallon EM, Kalish BT, et al. The role of the omega-3 fatty acid DHA in the human life cycle. J Parenter Enteral Nutr 2013; 37:15-22.
29. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: The antiinflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010; 68:280-289.
30. Spector AA, Fang Xiang, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function. Progress Lipid Res 2004; 43:55-90.
31. Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999; 285:1276-1279.
32. Bagga D, Wang L, Farias-Eisner R, et al. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 2003; 100:1751-1756.
33. Han YY, Lai SL, Ko WJ, et al. Effects of fish oil on inflammatory modulation in surgical intensive care unit patients. Nutr Clin Pract 2012; 27:91-98.
34. Sungurtekin H, Deg? irmenci S, Sungurtekin U, et al. Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis. Nutr Clin Pract 2011; 26:665-671.
35. Le HD, Meisel JA, de Meijer VE, et al. The essentiality of arachidonic acid and docosahexaenoic acid. Prostaglandins Leukot Essent Fatty Acids 2009; 81:165-170.
36. Nehra D, Fallon EM, Puder M. The prevention and treatment of intestinal failure-associated liver disease in neonates and children. Surg Clin North Am 2011; 91:543-563.
37. de Meijer VE, Gura KM, Meisel JA, et al. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg 2010; 145:547-551.
38. de Meijer VE, Le HD, Meisel JA, et al. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010; 50:212-218.
39. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009; 250:395-402.
40. de Meijer VE, Gura KM, Le HD, et al. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: The Boston experience. J Parenter Enteral Nutr 2009; 33:541-547.
41. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008; 121:e678-e686.
42. Gura K, Strijbosch R, Arnold S, et al. The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract 2007; 22:664-672.
43. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutritionassociated liver disease in two infants with short bowel syndrome using parenteral fish oil: Implications for future management. Pediatrics 2006; 118:e197-e201.
44. Gura KM, Parsons SK, Bechard LJ, et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005; 24:839-847.
45. Reniers D, Rajakumar I, Ratko S, Atkison P. Use of parenteral fish oil to reverse cholestasis induced by parenteral nutrition in infants with intestinal failure: Single-centre case series. Can J Hosp Pharm 2012; 65:27-30.
46. Sant'Anna AM, Altamimi E, Clause RF, et al. Implementation of a multidisciplinary team approach and fish oil emulsion administration in the management of infants with short bowel syndrome and parenteral nutrition-associated liver disease. Can J Gastroenterol 2012; 26:277-280.
47. Muhammed R, Bremner R, Protheroe S, et al. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr 2012; 54:797-802.
48. Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil medium-chain triglycerides, and fish oil: A randomized double-blind study in preterm infants. J Parenter Enteral Nutr 2012; 36 (1 Suppl):81SY94S.
49. Lilja HE, Finkel Y, Paulsson M, Lucas S. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions. J Pediatr Surg 2011; 46:1361-1367.
50. Pawlik D, Lauterbach R, Hurkáa J. The efficacy of fish-oil based fat emulsion administered from the first day of life in very low birth weight newborns. Med Wieku Rozwoj 2011; 15:306-311.
51. Nehra D, Fallon EM, Carlson SJ, et al. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. J Parenter Enteral Nutr 2012. [Epub ahead of print]
52. Cober MP, Killu G, Brattain A, et al. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr 2012; 160:421-427.
53. Luchtman DW, Song C. Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal studies and clinical studies. Neuropharmacology 2013; 64: 550-565.
54. Campoy C, Escolano-Margarit MV, Anjos T, et al. Omega 3 fatty acids on child growth, visual acuity and neurodevelopment. Br J Nutr 2012; 107 (Suppl 2): S85-S106.
55. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007; 137:855-859.
56. McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr 2005; 82:281-295.
57. Uauy R, Hoffman DR, Mena P, et al. Term infant studies of DHA and ARA supplementation on neurodevelopment: Results of randomized controlled trials. J Pediatr 2003; 143 (4 Suppl):S17-S25.
58. Uauy R, Mena P, Rojas C. Essential fatty acids in early life: Structural and functional role. Proc Nutr Soc 2000; 59:3-15.